Table 1.
| Characteristic |
Value (N=185) |
|---|---|
| Maternal data | |
| Age (y), mean (range) | 29.6 (20-41) |
| Trimester (No./total No. [%]) | |
| First | 3/185 (1.62) |
| Second | 5/185 (2.70) |
| Third | 177/185 (95.68) |
| Signs and symptoms (No./total No. [%]) | |
| Fever | 90/169 (53.25) |
| Pneumonia | 75/184 (40.76) |
| Cough | 56/169 (33.13) |
| Asymptomatic | 44/169 (26.03) |
| Dyspnea/shortness of breath | 22/169 (13.01) |
| Gastrointestinal alterations | 9/169 (5.32) |
| ICU admission | 6/185 (3.24) |
| Diagnostic method (No./total No. [%]) | |
| qRT-PCR SARS-CoV-2 only | 179/185 (96.75) |
| CT changes only | 6/185 (3.24) |
| qRT-PCR SARS-CoV-2 and CT changes | 100/185 (54.05) |
| Laboratory alterations | |
| Lymphopenia | 32/93 (34.40) |
| Neutrophilia | 8/93 (8.60) |
| Interventions (No./total No. [%]) | |
| Antibiotics | 64/145 (44.13) |
| Supportive measures | 41/145 (28.27) |
| Antiviral therapy | 39/145 (26.90) |
| Corticosteroids | 12/145 (8.28) |
| Obstetric comorbidities (No./total No. [%])c | |
| Gestational hypertension | 6/182 (3.29) |
| Preeclampsia | 4/182 (2.20) |
| Gestational diabetes | 11/182 (6.04) |
| Prelabor rupture of membranes | 13/184 (7.07) |
| Fetal distress | 23/184 (12.50) |
| Patient status (No./total No. [%]) | |
| Delivered | 152/185 (82.16) |
| Still pregnant | 33/185 (17.83) |
| Mode of delivery (No./total No. [%]) | |
| Cesarean delivery | 129/152 (84.86) |
| Vaginal delivery | 19/152 (12.50) |
| Pregnancy termination | 4/152 (2.63) |
| Gestational age at delivery of viable pregnancies (No./total No. [%]) | |
| <28 wk | 0/148 (0.00) |
| 28-31 6/7 wk | 2/148 (1.35) |
| 32-35 6/7 wk | 26/148 (17.56) |
| ≥36 wk | 96/148 (64.86) |
| Missing data | 24/148 (16.21) |
| Neonatal data | |
|---|---|
| Neonates reported (No./total No. [%]) | |
| Total | 146 (100) |
| Live births | 145/146 (99.31) |
| Stillbirths | 1/146 (0.68) |
| Comorbidities after live birth (No./total No. [%]) | |
| Neonatal ICU admission | 27/145 (18.62) |
| Low birth weight | 15/145 (10.34) |
| Pneumonia | 9/145 (6.20) |
| qRT-PCR SARS-CoV-2 positive | 2/145 (1.37) |
| Neonatal death | 1/145 (0.69) |
a
COVID-19 = coronavirus disease 2019; CT = computed tomography; ICU = intensive care unit; qRT-PCR = quantitative reverse transcriptase polymerase chain reaction; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
b
Note that certain parameters were not evaluated or reported in all patients, so the denominators used for calculations represent only the numbers for which data are available.
c
Thirty-three of 185 patients (17.8%) were still pregnant at the end of this study; therefore, rates of complications occurring in late pregnancy or close to delivery, such as preeclampsia, might have been underestimated.